kaiser permanente glp-1 coverage news An employer's guide to GLP-1s for obesity Perspectives from employers on the

A user moving to a higher strength shared a story many could relate to: "Going from 1mg to 2mg I had the WILDEST dreams (mostly nightmares)." - notataxprof Some people only recall a few incidents

Melanotan I is available as the approved drug Scenesse for erythropoietic protoporphyria

R., DiMarco, N

Given that type 2 diabetes itself is a risk factor for nonarteritic anterior ischemic optic neuropathy [which constitutes approximately 75% of ischemic optic neuropathy cases] the potential for GLP-1 receptor agonists to further augment this risk has relevant implications for clinical decision making.

Specific signals to hold at your current dose rather than escalating: you are losing 1 to 2 lb per week consistently